Exploring the EPIcenter of VEOIBD: defining the genetic drivers of intestinal epithelial cellular dysfunction-authors' reply [0.03%]
探究VEOIBD的EPI中心：定义肠道上皮细胞功能障碍的遗传驱动因素——作者回复
Zahra Shojaei Jeshvaghani,Edward Nieuwenhuis,Ewart Kuijk
Zahra Shojaei Jeshvaghani
Trends in Use of Prescribed Opioids in Incident and Prevalent Patients With Ulcerative Colitis: A Nationwide Study in Sweden [0.03%]
瑞典溃疡性结肠炎新发和现存患者的处方阿片类药物使用趋势：一项全国范围的研究
Mehdi Osooli,Siri Voghera,Gustaf Bruze et al.
Mehdi Osooli et al.
Background and aims: Opioids are not optimal for managing pain among patients with ulcerative colitis (UC), but the use of opiods in nationwide UC populations remains unexplored. We aimed to describe dispensed opioid use ...
Black and Latino/a Participants With Inflammatory Bowel Disease Are More Likely to Be at Risk for Post-Traumatic Stress Than Their White Counterparts: A Matched Control Comparison Study [0.03%]
与白人对照组相比，患炎症性肠病的黑人和拉丁裔患者更易产生创伤后应激障碍：匹配病例对照研究
Sara H Marchese,Hasan S Raza,Sandra Naffouj et al.
Sara H Marchese et al.
Introduction: Post-traumatic stress disorder (PTSD) is diagnosed when a person experiences chronic psychological distress following a traumatic event that involves a real or perceived threat to life or bodily harm. Up to ...
Combination Therapy With Fecal Microbiota Transplantation and Vedolizumab for Induction of Remission in Ulcerative Colitis: An Open-Label Pilot Study [0.03%]
溃疡性结肠炎组合疗法（粪菌移植和 vedolizumab 诱导缓解）：开放标签试点研究
Saad Syed,Paul Moayyedi,Dina Kao et al.
Saad Syed et al.
Real-World Outcomes of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Obese Patients With Ulcerative Colitis and IPAA With a History of Pouchitis [0.03%]
肥胖伴发溃疡性结肠炎和既往有储袋炎史的IPAA患者使用胰高血糖素样肽-1受体激动剂治疗的预后
Aakash Desai,Hany Habib,Himsikhar Khataniar et al.
Aakash Desai et al.
Introduction: There are limited data on the impact of glucagon-like peptide-1 receptor agonist (GLP-1RA) on the risk of recurrent pouchitis after ileal pouch-anal anastomosis (IPAA) for ulcerative colitis (UC). ...
Characterization of Computed Tomography Colonography Findings of Ulcerative Colitis-Associated Neoplasia [0.03%]
溃疡性结肠炎相关肿瘤的CT结肠成像表现特点分析
Yuta Kaieda,Shinya Sugimoto,Tatsuya Suzuki et al.
Yuta Kaieda et al.
Background: Computed tomography colonography (CTC) is increasingly utilized for the evaluation of colorectal neoplasms. However, in patients with ulcerative colitis (UC), current European Crohn's and Colitis Organisation ...
Bowel Wall Thickness Cutoff Value for Assessing Inflammatory Bowel Disease Activity Using Intestinal Ultrasonography in Children [0.03%]
儿童肠道超声评估炎症性肠病活动度的肠壁厚度临界值
Laura Räisänen,Ray Lang,Michael Couper et al.
Laura Räisänen et al.
Background and aims: Intestinal ultrasonography (IUS) is a noninvasive tool for assessing bowel inflammation. In adults, a bowel wall thickness (BWT) cutoff of 0.30 cm is used to indicate inflammation, but children do not...
Thromboembolic Risk in Ulcerative Colitis Patients on Advanced Therapy: A Real-World Data Analysis [0.03%]
溃疡性结肠炎患者使用诱导和维持治疗的血栓风险：真实世界数据分析
Yu Nishida,Shuhei Hosomi,Koji Fujimoto et al.
Yu Nishida et al.
Background and aims: Patients with ulcerative colitis (UC) have an elevated thromboembolic risk. The comparative risks associated with advanced therapies (ADTs) remain unclear. ...
Reply: "Early Switching to Subcutaneous Infliximab as a Pragmatic Strategy for Optimized Inflammatory Bowel Disease Care" [0.03%]
关于《早期切换至英夫利西单抗皮下注射作为优化炎症性肠病治疗的实用策略》的回复
Lorenzo Bertani,Davide Giuseppe Ribaldone,Fabrizio Bossa et al.
Lorenzo Bertani et al.
The Risk of Relapse Associated With Discontinuation of 5-Aminosalicylates in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis [0.03%]
5-氨基水杨酸制剂在炎症性肠病中停药后复发风险的系统评价和meta分析
Arteen Arzivian,David T Rubin,Cynthia H Seow et al.
Arteen Arzivian et al.
Background: Mesalamine (5-aminosalicylic acid, [5-ASA]) is the first-line therapeutic agent in mild-to-moderate ulcerative colitis (UC). The continuous use of 5-ASA involves costs, adverse effects, and delayed treatment e...